Pulmonary hypertension (PH) is a persistently progressive, incurable,
multifactorial associated fatal pulmonary vascular disease characterized by
pulmonary vascular remodeling. Long noncoding RNAs (lncRNAs) are involved in
regulating pathological processes such as pulmonary vasoconstriction, thickening,
remodeling, and inflammatory cell infiltration in PH by acting on different cell
types. Because of their differential expression in PH patients, as demonstrated
by the observation that some lncRNAs are significantly upregulated while others
are significantly downregulated in PH patients, lncRNAs are potentially useful
biomarkers for assessing disease progression and diagnosis or prognosis in PH
patients. This article provides an overview of the different mechanisms by which
lncRNAs are involved in the pathogenesis of PH.